Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cloretazine in acute myeloid leukemia
NCT00112554Phase 3Completed
- Sponsor
- Vion Pharmaceuticals
- Start
- Mar 2005
- Primary completion
- Mar 2008
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of laromustine in acute myeloid leukemia (AML), sponsored by Vion Pharmaceuticals. Started Mar 2005; status: completed.
02
Drugs
laromustine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00112554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00112554.